Insider Transactions in Q2 2025 at Yumanity Therapeutics, Inc. (YMTX)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 30
2025
|
Keith Baker Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
247,933
-100.0%
|
-
|
|
Jun 30
2025
|
Shawn Iadonato |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
8,553
-100.0%
|
-
|
|
Jun 30
2025
|
Shawn Iadonato |
SELL
Sale (or disposition) back to the issuer
|
Direct |
860,377
-100.0%
|
-
|
|
Jun 30
2025
|
Thierry Guillaudeux Chief Scientific Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
217,333
-100.0%
|
-
|
|
Jun 30
2025
|
Marion R Foote |
SELL
Sale (or disposition) back to the issuer
|
Direct |
165,156
-100.0%
|
-
|
|
Jun 30
2025
|
Kimberlee C Drapkin |
SELL
Sale (or disposition) back to the issuer
|
Direct |
13,794
-100.0%
|
-
|
|
Jun 30
2025
|
Richard Peters |
SELL
Sale (or disposition) back to the issuer
|
Direct |
101,891
-100.0%
|
-
|
|
Jun 30
2025
|
Craig W. Philips President and Secretary |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
34,654
-100.0%
|
-
|
|
Jun 30
2025
|
Craig W. Philips President and Secretary |
SELL
Sale (or disposition) back to the issuer
|
Direct |
298,464
-100.0%
|
-
|
|
Jun 30
2025
|
Scott J. Dylla |
BUY
Sale (or disposition) back to the issuer
|
Direct |
17,794
+100.0%
|
-
|
|
Jun 30
2025
|
David Arkowitz |
SELL
Sale (or disposition) back to the issuer
|
Direct |
16,571
-100.0%
|
-
|
|
Jun 30
2025
|
Raymond J. Bartoszek |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
1,750,474
-100.0%
|
-
|
|
Jun 30
2025
|
Raymond J. Bartoszek |
SELL
Sale (or disposition) back to the issuer
|
Direct |
31,000
-100.0%
|
-
|
|
Jun 25
2025
|
Richard Peters |
BUY
Grant, award, or other acquisition
|
Direct |
6,000
+5.56%
|
-
|
|
Jun 25
2025
|
Kimberlee C Drapkin |
BUY
Grant, award, or other acquisition
|
Direct |
6,000
+30.31%
|
-
|
|
Jun 25
2025
|
Scott J. Dylla |
BUY
Grant, award, or other acquisition
|
Direct |
6,000
+25.22%
|
-
|
|
Jun 25
2025
|
Marion R Foote |
BUY
Grant, award, or other acquisition
|
Direct |
6,000
+3.51%
|
-
|
|
Jun 25
2025
|
Raymond J. Bartoszek |
BUY
Grant, award, or other acquisition
|
Direct |
6,000
+16.22%
|
-
|
|
Jun 25
2025
|
Thierry Guillaudeux Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
23,100
+9.61%
|
-
|
|
Jun 25
2025
|
Craig W. Philips President and Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
60,300
+16.81%
|
-
|
|
Jun 25
2025
|
David Arkowitz |
BUY
Grant, award, or other acquisition
|
Direct |
6,000
+24.85%
|
-
|
|
Jun 25
2025
|
Keith Baker Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
53,700
+17.8%
|
-
|
|
Jun 23
2025
|
Shawn Iadonato |
SELL
Payment of exercise price or tax liability
|
Direct |
52,353
-5.74%
|
$0
$0.26 P/Share
|
|
Jun 23
2025
|
Shawn Iadonato |
BUY
Exercise of conversion of derivative security
|
Direct |
237,500
+10.78%
|
$0
$0.49 P/Share
|
|
Jun 23
2025
|
Richard Peters |
SELL
Payment of exercise price or tax liability
|
Direct |
4,706
-4.68%
|
$0
$0.26 P/Share
|
|
Jun 23
2025
|
Richard Peters |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+11.05%
|
$0
$0.61 P/Share
|
|
Jun 23
2025
|
Kimberlee C Drapkin |
SELL
Payment of exercise price or tax liability
|
Direct |
4,706
-37.65%
|
$0
$0.26 P/Share
|
|
Jun 23
2025
|
Kimberlee C Drapkin |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+50.0%
|
$0
$0.61 P/Share
|
|
Jun 23
2025
|
Scott J. Dylla |
SELL
Payment of exercise price or tax liability
|
Direct |
4,706
-28.52%
|
$0
$0.26 P/Share
|
|
Jun 23
2025
|
Scott J. Dylla |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+43.1%
|
$0
$0.61 P/Share
|
|
Jun 23
2025
|
Marion R Foote |
SELL
Payment of exercise price or tax liability
|
Direct |
4,706
-2.87%
|
$0
$0.26 P/Share
|
|
Jun 23
2025
|
Marion R Foote |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+7.09%
|
$0
$0.61 P/Share
|
|
Jun 23
2025
|
Raymond J. Bartoszek |
SELL
Payment of exercise price or tax liability
|
Direct |
4,706
-15.84%
|
$0
$0.26 P/Share
|
|
Jun 23
2025
|
Raymond J. Bartoszek |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+29.62%
|
$0
$0.61 P/Share
|
|
Jun 23
2025
|
Thierry Guillaudeux Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
47,647
-19.7%
|
$0
$0.26 P/Share
|
|
Jun 23
2025
|
Thierry Guillaudeux Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
225,000
+47.7%
|
$0
$0.36 P/Share
|
|
Jun 23
2025
|
Craig W. Philips President and Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
47,647
-16.67%
|
$0
$0.26 P/Share
|
|
Jun 23
2025
|
Craig W. Philips President and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
225,000
+44.05%
|
$0
$0.36 P/Share
|
|
Jun 23
2025
|
David Arkowitz |
SELL
Payment of exercise price or tax liability
|
Direct |
4,706
-27.93%
|
$0
$0.26 P/Share
|
|
Jun 23
2025
|
David Arkowitz |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+42.59%
|
$0
$0.61 P/Share
|
|
Jun 23
2025
|
Keith Baker Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
47,647
-19.7%
|
$0
$0.26 P/Share
|
|
Jun 23
2025
|
Keith Baker Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
225,000
+48.19%
|
$0
$0.36 P/Share
|
|
Jun 17
2025
|
Marion R Foote |
BUY
Exercise of conversion of derivative security
|
Direct |
8,158
+5.11%
|
$0
$0.14 P/Share
|